Professor Gordon Cook

Improving treatments for patients with myeloma

Based at the University of Leeds, Professor Gordon Cook is running important clinical trials for patients with myeloma, a type of blood cancer that develops in the bone marrow. 

In myeloma, a type of blood cell called a plasma cell grows uncontrollably and overcrowds the bone marrow. As a form of intense treatment, some patients will have a procedure called a stem cell transplant. This involves taking out the patient’s blood-forming cells, killing their bone marrow cells and cancer cells with treatment, and then giving them back their healthy cells.

Through clinical trials, Professor Cook is hoping to improve this type of therapy for patients whose myeloma has come back after treatment. He’s looking at whether giving a second dose of this type of therapy is effective, and whether giving a newly developed drug help make the procedure more effective. In another, he’s looking at whether giving an extra chemotherapy drug boost the effectiveness of stem cell transplants in myeloma patients whose disease has returned.

If successful, these trials could change the way that some myeloma patients are treated, helping more people survive their disease.


Clinical trials

Leeds Institute of Cancer & Pathology, Wellcome Trust Brenner Building, University of Leeds